FDA Approved: CHOLESTYRAMINE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for cholestyramine filed by Ajanta Pharma USA Inc., indicating an update to the product's approved status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Cholestyramine (cholestyramine)

Snippet

SUPPL AP for CHOLESTYRAMINE (CHOLESTYRAMINE)